Citadel Advisors - UNITED THERAPEUTICS CORP DEL ownership

UNITED THERAPEUTICS CORP DEL's ticker is and the CUSIP is 91307C952. A total of 2 filers reported holding UNITED THERAPEUTICS CORP DEL in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of UNITED THERAPEUTICS CORP DEL
ValueSharesWeighting
Q2 2016$3,485,000
+3.2%
32,900
+8.6%
0.00%0.0%
Q1 2016$3,376,000
-15.5%
30,300
+18.8%
0.00%0.0%
Q4 2015$3,994,000
-5.5%
25,500
-20.8%
0.00%0.0%
Q3 2015$4,226,000
-34.0%
32,200
-12.5%
0.00%
-33.3%
Q2 2015$6,401,000
-8.1%
36,800
-8.9%
0.01%
-14.3%
Q1 2015$6,966,000
+120.4%
40,400
+65.6%
0.01%
+133.3%
Q4 2014$3,160,000
-98.9%
24,400
-98.9%
0.00%
-99.0%
Q3 2014$277,074,000
+9625.3%
2,153,700
+6588.5%
0.29%
+9566.7%
Q2 2014$2,849,000
+40.9%
32,200
+49.8%
0.00%
+50.0%
Q1 2014$2,022,000
-48.8%
21,500
-38.4%
0.00%
-60.0%
Q4 2013$3,946,000
+218.7%
34,900
+122.3%
0.01%
+150.0%
Q3 2013$1,238,000
-12.1%
15,700
-26.6%
0.00%0.0%
Q2 2013$1,409,00021,4000.00%
Other shareholders
UNITED THERAPEUTICS CORP DEL shareholders Q3 2016
NameSharesValueWeighting ↓
GROUP ONE TRADING, L.P. 22,400$5,016,7040.02%
JANE STREET GROUP, LLC 63,000$14,109,4800.01%
SIMPLEX TRADING, LLC 7,400$1,6570.00%
JPMORGAN CHASE & CO 19,200$4,300,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of UNITED THERAPEUTICS CORP DEL shareholders